Clinical Research on Penyanjing Granule Combined with Kangfu Xiaoyan Suppositories for Treatment of Sequela after Pelvic Inflammatory Disease

GE Jing; XIE Lei; LIU Jing; LI Yi-fei; DU Zhi-xiang; HUA Fang

您当前的位置：

首页 >

文章列表页 >

Clinical Research on Penyanjing Granule Combined with Kangfu Xiaoyan Suppositories for Treatment of Sequela after Pelvic Inflammatory Disease

更新时间：2024-09-23

- Clinical Research on Penyanjing Granule Combined with Kangfu Xiaoyan Suppositories for Treatment of Sequela after Pelvic Inflammatory Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 3, Pages: 303-305(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
GE Jing, XIE Lei, LIU Jing, et al. Clinical Research on Penyanjing Granule Combined with Kangfu Xiaoyan Suppositories for Treatment of Sequela after Pelvic Inflammatory Disease[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(3): 303-305.
DOI：

GE Jing, XIE Lei, LIU Jing, et al. Clinical Research on Penyanjing Granule Combined with Kangfu Xiaoyan Suppositories for Treatment of Sequela after Pelvic Inflammatory Disease[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(3): 303-305. DOI：

摘要

目的: 观察盆炎净颗粒结合康妇消炎栓治疗盆腔炎性疾病后遗症(SPID)的临床疗效及对血液流变学的影响。方法: 147例SPID患者随机分为治疗组74例和对照组73例。治疗组盆炎净颗粒口服

10 g/次

3次/d;康妇消炎栓外用

1粒/次

1次/d

疗程1个月经周期。对照组左氧氟沙星口服

0.2/次

2次/d;甲硝唑片口服

0.4 g/次

2次/d

疗程14 d。观察两组临床症状与体征

并检测血液流变学指标。结果: 治疗后治疗组症状、体征积分为(4.52±2.14)分

低于对照组的(10.57±3.75)分(P<0.01);治疗组血液流变各项指标改善也优于对照组(P<0.01);治疗组总有效率90.54%

优于对照组的78.08%(P<0.05)。结论: 盆炎净颗粒结合康妇消炎栓是治疗盆腔炎性疾病后遗症较好的治疗方案。

Abstract

Objective:To observe Penyanjing granule (PG) combined with Kangfu Xiaoyan suppositories (KXS) for treatment of sequela after pelvic inflammatory disease (SPID) and effect on hemorheological parameters. Method: One hundred and forty-seven cases of SPID were randomly divided into treatment group and control group

74 cases and 73 cases respectively.The treatment group was given PG orally

10 g tid; combined with KXS for external use

1 application daily. The period of treatment was lasted one menstrual cycle. The control group was given levofloxacin orally

0.2 g

bid and metronidazole tablets

0.4 g

bid. The course was 14 days. The clinical symptoms

signs and hemorheological parameters were observed for both groups. Result: After treatment

the scores of symptoms

signs and symptoms were(4.52±2.14) in treatment group

lower than that of(10.57±3.75)in the control group (P<0.01). The improvement of hemorheological parameters in treatment was also superior to those in the control group (P<0.01). The total curative rate in treatment group was 90.54%

better than 78.08% in control group (P<0.05). Conclusion: PG combined with KXS is an effective treatment for treating SPID. It is worth for clinical use.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Research on Penyanjing Granule Combined with Kangfu Xiaoyan Suppositories for Treatment of Sequela after Pelvic Inflammatory Disease

Effect of Qishao Huoxue Prescription on Hemorheological Parameters and Serum Levels of Inflammatory Mediators in Lumbar Disc Herniation Due to Qi Stagnation and Blood Stasis

Application of Insect Medicines in Treatment of Coronary Microvascular Dysfunction Based on Comorbidity Theory of "Blood-Vessel-Cardiac Collaterals"

Protection Mechanism of Addition and Subtraction Therapy of Danshenyin Combined with Wendantang for Myocardial Ischemia in Patients with Stable Angina

Effect of Erxian Decoction on Myocardial Microvessels and Hemorheology in Ovariectomized Rats

Related Author

GE Jing

XIE Lei

LIU Jing

LI Yi-fei

DU Zhi-xiang

HUA Fang

WANG Guojun

ZHANG Shimin

Related Institution

Gynaecology and Obstetrics Department,the First Hospital of Hebei Medical University

Wangjing Hospital of China Academy of Chinese Medical Sciences

Guang'anmen Hospital， China Academy of Chinese Medical Sciences

Hainan Hospital of Traditional Chinese Medicine

Haikou Affiliated Hospital of Central South University Xiangya School of Mcdicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰